Prescription drug data-mining company IMS Health, Parsippany, N.J., has acquired TTC, Philadelphia, a drug trials data-analytics company for drug manufacturers and drug contract research organizations, according to an IMS Health news release. Terms were undisclosed.
IMS acquires analytics company TTC
According to the release, IMS will offer TTC services through its clinical trial optimization unit, which is part of its healthcare value solutions business. “IMS will integrate its evidence-based, anonymized patient and treatment outcomes insights with TTC's comprehensive cost data drawn from organizations that conduct nearly 80% of all commercial clinical studies,” the statement said.
“There is growing demand for more data and analytics to optimize the clinical trial process,” said Linda Drumright, general manager of clinical trial optimization solutions at IMS, in the release. “Together, we can deliver an end-to-end view of trial planning and execution—increasingly critical at a time when the industry faces significant challenges and requires new approaches.”
IMS just announced that it acquired PharmaDeals, a Web-based subscription database that gathers information about the pharmaceutical industry.
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.